Barrier Therapeutics Financial Statements
Barrier Therapeutics Financial Information
| Company Type | Public Single Location |
|---|---|
| Fiscal Year-End | December |
This data is provided as per license from EDGAR Online
Barrier Therapeutics Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 24.1 | 6.7 | 2.5 |
| Gross Profit ($ mil.) | 20.9 | 5.3 | 2.0 |
| Operating Income ($ mil.) | (56.6) | (56.4) | (48.7) |
| Total Net Income ($ mil.) | (53.7) | (52.7) | (45.2) |
| Diluted EPS (Net Income) | (1.74) | (2.06) | (1.91) |
Barrier Therapeutics Quarterly Statements
| Quarter Ending Mar 08 | Quarter Ending Dec 07 | Quarter Ending Sep 07 | |
|---|---|---|---|
| Revenue ($ mil.) | 8.4 | 9.7 | 7.5 |
| Gross Profit ($ mil.) | 7.7 | 8.2 | 6.9 |
| Operating Income ($ mil.) | (14.3) | (11.7) | (12.7) |
| Total Net Income ($ mil.) | (14.0) | (10.1) | (12.5) |
| Diluted EPS (Net Income) | (0.40) | (0.26) | (0.41) |
